Regulatory context · 2026-03-31 · Read time: ~5 min.

HIPAA for EU companies - When US health-data regulation becomes relevant

HIPAA is US law and does not automatically apply to every EU organisation. It becomes relevant quickly when US partners, trial sites, or PHI-processing services are involved.

When HIPAA becomes relevant for EU teams

  • Collaboration with US hospitals or US research entities.
  • Clinical programmes involving US sites or US subsidiaries.
  • Service delivery for US organisations where PHI is processed.

Covered Entities and Business Associates

EU providers may become Business Associates when processing PHI for Covered Entities. This creates specific contractual and security obligations that differ from EU-only setups.

Compared to GDPR, HIPAA frames consent, purpose limits, and breach duties differently. Upfront mapping and contract clarity are therefore essential.

Technical implications

For bioinformatics systems with US touchpoints, data location, access boundaries, encryption, logging, and breach workflow readiness are critical.

When PHI-related flows span tools and regions, teams should explicitly model role boundaries, key control, and export paths.

What this article is not

  • Not US legal advice.
  • Not a HIPAA certification claim for any specific product.

Sources

This article is an overview (as of 2026-03-31). For binding interpretation under US law, consult specialised US counsel.

Last updated: 2026-03-31

Related context

EHDS - What the European Health Data Space technically requires from hospitals and research organisations

Relevance for Synaptic Four

Ferrum and BioResearch Assistant are designed for operation in your own infrastructure, which can support data localisation and controlled access patterns.

Security building blocks are not HIPAA certification, but can provide a useful technical baseline in appropriate architectures.

Ferrum is the practical starting point for platform-level implementation.

Ferrum